Hidetoshi Tahara

Last Updated :2019/11/01

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Pharmaceutical Sciences), ., Professor
E-mail
toshihiroshima-u.ac.jp
Self-introduction
My research fields are Telomere, microRNA and exosome in aging and cancer.

Basic Information

Major Professional Backgrounds

  • 2000/05/01, 2001/03/31
  • 1994/10/01, 2000/04/30
  • 2006/04/01
  • 2002/04/01, 2006/03/31
  • 2002/04/01, 2006/03/31
  • 2001/04/01, 2002/03/31

Educational Backgrounds

  • Hiroshima University, Graduate School, Division of Medical Sciences, Japan, 1991/04, 1994/03
  • Tokyo University of Pharmacy and Life Science, Faculty of Pharmaceutical Science, Japan, 1985/04, 1989/03

Academic Degrees

  • Doctor of Philosophy in Pharmaceutical Science, Hiroshima University
  • Master of Pharmaceutical Science, Hiroshima University

Research Fields

  • Biological Sciences;Oncology;Tumor biology
  • Biological Sciences;Oncology;Tumor diagnostics

Research Keywords

  • Telomerase
  • Immortalization
  • Telomere
  • Cellular senescence
  • microRNA
  • Exosome
  • Extracellular vesicles
  • Biomarker

Affiliated Academic Societies

  • American Assciation for Cancer Research
  • Japanese RNAi association, 2008
  • Japanese Society of Extracellular Vesicles, 2014

Educational Activity

Course in Charge

  1. 2019, Undergraduate Education, 4Term, Biochemistry V
  2. 2019, Undergraduate Education, First Semester, Practice of xenobiotics and molecular toxicology
  3. 2019, Undergraduate Education, 1Term, Biochemistry VI
  4. 2019, Undergraduate Education, 4Term, Cell Biology
  5. 2019, Undergraduate Education, Second Semester, Experiments of Cellular and Molecular Biology
  6. 2019, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences I
  7. 2019, Undergraduate Education, Year, Special laboratory Works in Pharmaceutical Sciences II
  8. 2019, Undergraduate Education, Second Semester, Special laboratory Works in Pharmaceutical Sciences III
  9. 2019, Graduate Education (Master's Program) , First Semester, Methods in biomedical sciences
  10. 2019, Graduate Education (Master's Program) , First Semester, Methods in biomedical sciences
  11. 2019, Graduate Education (Master's Program) , First Semester, Methods in biomedical sciences
  12. 2019, Graduate Education (Master's Program) , First Semester, Methods in biomedical sciences
  13. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Methods in biomedical sciences
  14. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Methods in biomedical sciences
  15. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Methods in biomedical sciences
  16. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Lecture on Methods in biomedical sciences
  17. 2019, Graduate Education (Master's Program) , First Semester, Seminar on health policy & global health
  18. 2019, Graduate Education (Master's Program) , 3Term, Advanced lecture on cell regeneration
  19. 2019, Graduate Education (Master's Program) , First Semester, Seminar on cell regeneration
  20. 2019, Graduate Education (Master's Program) , Second Semester, Seminar on cell regeneration
  21. 2019, Graduate Education (Master's Program) , First Semester, Research on cell regeneration
  22. 2019, Graduate Education (Master's Program) , Second Semester, Research on cell regeneration
  23. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced seminar on Cellular and Molecular Biology
  24. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced seminar on Cellular and Molecular Biology
  25. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced research on Cellular and Molecular Biology
  26. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced research on Cellular and Molecular Biology
  27. 2019, Graduate Education (Master's Program) , 1Term, Seminar on Health Policy & Global Health
  28. 2019, Graduate Education (Master's Program) , 1Term, Methods in Biomedical Sciences A
  29. 2019, Graduate Education (Doctoral Program) , 1Term, Methods in Biomedical Sciences B
  30. 2019, Graduate Education (Doctoral Program) , 3Term, Methodology of Education for Creation and Development of Biomedical Sciences
  31. 2019, Graduate Education (Doctoral Program) , 3Term, Methodology of Education for Creation and Development of Biomedical Sciences
  32. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Cellular and Molecular Biology
  33. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Cellular and Molecular Biology
  34. 2019, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Cellular and Molecular Biology
  35. 2019, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Cellular and Molecular Biology
  36. 2019, Graduate Education (Master's Program) , 3Term, Lecture on Mechanisms of Signal Transduction
  37. 2019, Graduate Education (Master's Program) , First Semester, Seminar on Cell Regeneration
  38. 2019, Graduate Education (Master's Program) , Second Semester, Seminar on Cell Regeneration
  39. 2019, Graduate Education (Master's Program) , First Semester, Research on Cell Regeneration
  40. 2019, Graduate Education (Master's Program) , Second Semester, Research on Cell Regeneration

Research Activities

Academic Papers

  1. DSE-FRET: A new anticancer drug screening assay for DNA binding proteins, CANCER SCIENCE, 105(7), 870-874, JUL 2014
  2. Decreased Amyloid-beta Pathologies by Intracerebral Loading of Glycosphingolipid-enriched Exosomes in Alzheimer Model Mice, JOURNAL OF BIOLOGICAL CHEMISTRY, 289(35), 24488-24498, AUG 29 2014
  3. A potential function for neuronal exosomes: Sequestering intracerebral amyloid-beta peptide, FEBS LETTERS, 589(1), 84-88, JAN 2 2015
  4. EVpedia: a community web portal for extracellular vesicles research, BIOINFORMATICS, 31(6), 933-939, MAR 15 2015
  5. Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture, PLOS ONE, 9(11), NOV 12 2014
  6. Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients, CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(12), 2117-2122, DEC 2014
  7. Telomere G-tail Length is a Promising Biomarker Related to White Matter Lesions and Endothelial Dysfunction in Patients With Cardiovascular Risk: A Cross-sectional Study, EBIOMEDICINE, 2(8), 960-967, AUG 2015
  8. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer, ONCOTARGET, 7(7), 8223-8239, 20160216
  9. Expression of CDK inhibitor p21 and CDK2 in human colorectal carcinoma cell lines: relation with p53 status, Recent Advances in Gastroenterological Carcinogenesis., 749-753, 99990101
  10. Inhibition of membrane Ca2+ ATPase of Saccharomyces cerevisiae by mating pheromone a factor in vitro, J. Gen. Microbiol.=, 137, 1-4, 19920401
  11. DNA-DNA Subtractive cDNA cloning using Oigo (dt)(30) -Latex and PCR-identification of cellular genes which are overexpressed in senescent human diploid fibroblasts., Anal Biochem, 214, 58-64, 19930401
  12. DNA-DNA subtractive cDNA cloning using oligo(dT)30-latex and PCR: Identification of cellular genes which are overexpressed in senescent human diploid fibroblasts., Anal Biochem, 214, 58-64, 19930401
  13. DNA-DNA subtractive cDNA cloning using oligo(dT)30-Latex and PCR: identification of cellular genes which are overexpressed in senescent human diploid fibroblasts, Anal Biochem, 214(1), 58-64, 19930401
  14. Preparation of subtractive cDNA library enriches in cDNAs which expressed at high level in cultured senescent human fibroblasts, Biochem. Biophys. Res. Commun., 199, 1108-1112, 19940401
  15. Preparation of a substractive cDNA library enriched in cDNAs which expressed at a high level in cultured senescent human fibroblasts., Biochem. Biophys. Res. Commun., 199, 1108-1112, 19940401
  16. Preparation of a subtractive cDNA library enriched in cDNAs which expressed at a high level in cultured senescent human fibroblasts, Biochem. Biophys. Res. Commun., 199(3), 1108-1112, 19940401
  17. Telomerase activity in human liver tissues : Comparison between chronic liver disease and hepato cellular carcinoma., Cancer Research, 55, 2734-2736, 19950401
  18. Increase in expression level of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan, Oncogene, 10, 1125-1132, 19950401
  19. Inhibitors of cGMP-dependent protein kinase block seescence induced by inactivation of T antigen in SV40-fransformed immortal human fibroblasts, Oncogene, 11, 627-634, 19950401
  20. Telomerase activity in preneoplastic and neoplastic gastric and colovectal lesions, Clinical Cancer Research, 1, 1245-1251, 19950401
  21. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas., Cancer Res., 55, 2734-2736, 19950401
  22. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts., Oncogene, 10, 835-840, 19950401
  23. Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan., Oncogene, 11, 1125-1132, 19950401
  24. Inhibitors of cGMP-dependent protein kinase block senescence induced by inactivation of T antigen in SV40-transformed immortal human fibroblasts., Oncogene, 11, 627-634, 19950401
  25. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3., Jpn.J.Cancer Res., 86, 899-904, 19950401
  26. Telomerase activity in precancerous and cancerous lesions of gastric and colorectal tissues., Clinical Cancer Res., 1, 1245-1251, 19950401
  27. Inhibitors of cGMP-dependent protein kinase block senescence induced by inactivation of T antigen in SV40-transformed immortal human fibroblasts, Oncogene, 11(4), 627-634, 19950401
  28. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3, Jpn.J.Cancer Res., 86(10), 899-904, 19950401
  29. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions, Clin. Cancer Res., 1(11), 1245-1251, 19950401
  30. Increase in expression levels of interferon-inducible genes in senescent human diploid fibroblasts and in SV40-transformed human fibroblasts with extended lifespan, Oncogene, 11(6), 1125-1132, 19950401
  31. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas, Cancer Res., 55(13), 2734-2736, 19950401
  32. Increase in expression level of p21sdi1/cip1/waf1 with increasing division age in both normal and SV40-transformed human fibroblasts, Oncogene, 10(5), 835-840, 19950401
  33. Telomerase, 23, 247-256, 19960401
  34. Telomerase in hepatocellular carcinogenesis., Human Cell, 9, 283-286, 19960401
  35. Telomerase activity in normal human epithelial cells., Oncogene, 13, 433-439, 19960401
  36. Telomerase activity in human breast cancer and benign breast lesions: Diagnostic applications in clinical specimens, including fine needle aspirates., Int J Cancer, 69, 301-306, 19960401
  37. Telomerase activity in various precancerous and cancer tissues, The Proceedings of 87th Annual Meeting of the American Association for Cancer Reserch, 19960401
  38. Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells, Jpn.J.Cancer Res., 87(4), 377-384, 19960401
  39. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines, Jpn.J.Cancer Res., 87(8), 824-830, 19960401
  40. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence, Mol. Cell. Biol., 16(3), 859-867, 19960401
  41. Telomerase in hepatocellular carcinogenesis, Hum Cell, 9(4), 283-286, 19960401
  42. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates, Int J Cancer, 69(4), 301-306, 19960401
  43. Molecular biological observations in gastric cancer, Semin Oncol, 23(3), 307-315, 19960401
  44. Telomerase activity in normal human epithelial cells, Oncogene, 13(2), 433-439, 19960401
  45. Genetic Status and Expression of the Cyclin-dependent Kinase Inhibitors in Human Gastric Carcinoma cell Lines, Jpn.J.Cancer Res., 87, 824-830, 19960101
  46. Alteration of telomeric repeat length in hepatocellular carcinoma is independent of telomerase activity., Int J Oncol, 11, 139-143, 19970401
  47. Immortakization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity., Differentiation, 62, 203-211, 19970401
  48. Telomerase activity in ovarian tumors., Cancer, 80, 1085-1092, 19970401
  49. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinomas., Int J Cancer, 74, 141-147, 19970401
  50. Loss of amplified telomeric sequences associated with senescence in telomerasenegative SUSM-1 cells by introduction of human chromosome 7., Exp Cell Res, 235, 345-353, 19970401
  51. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay(HPA)connected with telomeric repeat amplification protocol(TRAP)., J. Cancer Res. Oncol., 123, 337-344, 19970401
  52. Alteration of telomeric repeat length in hepatocellular carcinoma is independent of telomerase activity., Int J Oncol, 11, 139-143, 19970401
  53. Telomerase activity in ovarian tumors., Cancer, 80, 1085-1092, 19970401
  54. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinomas., Int J Cancer, 74, 141-147, 19970401
  55. Loss of amplified telomeric sequences associated with senescence in telomerase-negative SUSM-1 cells by introduction of human chromosome 7., Exp Cell Res, 235, 345-353, 19970401
  56. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay (HPA) connected with telomeric repeat amplification protocol (TRAP)., J Cancer Res Clin Oncol, 123, 337-344, 19970401
  57. Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity., Diffrentiation, 52, 203-211, 19970401
  58. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol, Journal of Cancer Research and Clinical Oncology, 123(6), 337-344, 19970401
  59. Telomerase activity in premalignant and malignant lesions of human oral mucosal, 6(6), 413-420, 19970401
  60. Immortalization of immunologically committed Epstein-Barr virus-transformed human B-lymphoblastoid cell lines accompanied by a strong telomerase activity, Differentiation, 62(4), 203-211, 19970401
  61. Expression of human telomerase RNA is an early event of stomach carcinogenesis, Japanese Journal of Cancer Research, 88(2), 103-107, 19970401
  62. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27(Kip1) in a human gastric carcinoma cell line, 8(1), 47-52, 19970401
  63. Telomerase activity in ovarian tumors, Cancer, 80(6), 1085-1092, 19970401
  64. Decrease in amplified telomeric sequences and induction of senescence markers by introduction of human chromosome 7 or its segments in SUSM-1, Experimental Cell Research, 235(2), 345-353, 19970401
  65. Alteration of telomeric repeat length in hepatocellular carcinoma is independent of telomerase activity, INTERNATIONAL JOURNAL OF ONCOLOGY, 11(1), 139-143, 19970401
  66. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma, International journal of cancer, 74(2), 141-147, 19970401
  67. Modified trap assay for the diagnosis of small differentiated hepatocellular carcinoma (HCC)., Gastroenterology, 112(4), A1344-A1344, 19970401
  68. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine, Cancer, 79(2), 362-369, 19970401
  69. Telomere and telomerase in Gastrointestinal cancers, 245-259., 19970401
  70. A hVti1 homologue : Its expression depends on population doubling levels in both normal and SV40-transformed human fibroblasts., Biochem. Biophys. Res. Commun., 247, 70-74, 19980401
  71. Telomerase activation by the catalytic component gene TRT in human primary fibroblasts and hepatocellular carcinomas., Nature genetics, 18, 65-68, 19980401
  72. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinogenesis, Jpn.J.Cancer Res., 1187-1194, 19980401
  73. Telomerase activation by the catalytic component gene TRT in human primary fibroblasts and hepatocelluar carcinomas., Nature Genet., 18, 65-68, 19980401
  74. Extra-chromosomal telomere repeat DNA in telomerase-negative immortalized cell lines., Biochem. Biophys. Res. Commun., 247, 765-772, 19980401
  75. A hVti1 homologue: its expression depends on population doubling levels in both normal and SV40-transformed human fibroblasts., Biochem. Biophys. Res. Commun., 247, 70-74, 19980401
  76. A new method to detect and measure telomerase activity by transcription-mediated amplification (TMA) and hybridization protection assay (HPA)., Clinical Chem., 44, 2446-2452, 19980401
  77. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions., Jpn.J.Cancer Res., 89, 1099-1103, 19980401
  78. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas., Jpn.J.Cancer Res., 89, 1187-1194, 19980401
  79. Telomerase activity in lesions of the thyroid: Application to diagnosis of clinical samples including fine-needle aspirates, Clinical Cancer Research, 4(8), 1965-1970, 19980401
  80. New method to measure telomerase activity by transcription-mediated amplification and hybridization protection assay, Clinical Chemistry, 44(12), 2446-2452, 19980401
  81. In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions, Japanese Journal of Cancer Research, 89(11), 1187-1194, 19980401
  82. A hVti1 homologue: Its expression depends on population doubling levels in both normal and SV40-transformed human fibroblasts, Biochemical and Biophysical Research Communications, 247(1), 70-74, 19980401
  83. Diagnostic value of telomerase activity in gynecologic malignancies, International Journal of Gynecological Cancer, 8(6), 481-488, 19980401
  84. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas, Nature genetics, 18(1), 65-68, 19980401
  85. A quantitative method to measure telomerase activity by hybridization protectin assay (HPA) connected with TRAP for the diagnosis of hepatocellular carcinoma (HCC)., Gastroenterology, 114(4), A1351-A1351, 19980401
  86. Extra-chromosome telomere repeat DNA in telomerase-negative immortalized cell lines, Biochemical and Biophysical Research Communications, 247(3), 765-772, 19980401
  87. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas, Japanese Journal of Cancer Research, 89(11), 1099-1103, 19980401
  88. Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology, Pathol. Int., 49, 763-774, 19990401
  89. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections., Oncogene, 18, 1561-1567, 19990401
  90. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach., Jpn.J.Cancer Res., 90, 589-595, 19990401
  91. Telomerase activity in central nervous system malignant lymphoma., Cancer, 86, 1050-1055, 19990401
  92. Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality., Mech. Ageing Dev., 110, 175-193, 19990401
  93. Quantitative re-evaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues., Mol. Carcinog., 26, 312-320, 19990401
  94. Telomerase activity in central nervous system malignant lymphoma, Cancer, 86(6), 1050-1055, 19990401
  95. Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality, Mechanisms of Ageing and Development, 110(3), 175-193, 19990401
  96. Effect of antisense human telomerase RNA transfection on the growth of human gastric cancer cell lines, Biochemical and Biophysical Research Communications, 255(3), 753-758, 19990401
  97. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues, Molecular Carcinogenesis, 26(4), 312-320, 19990401
  98. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections, Oncogene, 18(8), 1561-1567, 19990401
  99. Molecular-pathological diagnosis of gastrointestinal tissues and its contribution to cancer histopathology, Pathology International, 49(9), 763-774, 19990401
  100. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach, Japanese Journal of Cancer Research, 90(6), 589-595, 19990401
  101. Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation., Surg. Neural, 267-274, 20000401
  102. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker., J Neurosurg, 618-625, 20000401
  103. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis, Cancer Letters, 149, 125-134, 20000401
  104. Expression of telomerase component genes in hepatocellular carcinomas., Eur. J. Cancer, 36, 496-502, 20000401
  105. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues., Oncogene, 19, 3888-3893, 20000401
  106. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker., J Neurosurg, 93, 618-625, 20000401
  107. Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity., J. Neurooncol., 47, 39-46, 20000401
  108. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis, Cancer Letters, 149(2001/01/02), 125-134, 20000401
  109. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker, Journal of Neurosurgery, 93(4), 618-625, 20000401
  110. Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity, Journal of Neuro-Oncology, 47(1), 39-46, 20000401
  111. Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation, Surgical Neurology, 53(3), 267-274, 20000401
  112. Immuno-histochemical detection of human telomerase reverse transcriptase in human liver tissues, Oncogene, 19(34), 3888-3893, 20000401
  113. Immortalization of mammary cells from estrogen receptor alpha knock-out and wild-type mice, In Vitro Cellular of Developmental Biology, 36(10), 620-624, 20000401
  114. Expression of telomerase component genes in hepatocellular carcinomas, European Journal of Cancer, 36(4), 496-502, 20000401
  115. Cloning of a human hepatocyte growth factor/scatter factor transcription variant from a gastric cancer cell line HSC-39, INTERNATIONAL JOURNAL OF ONCOLOGY, 16(1), 105-108, 20000401
  116. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker, JOURNAL OF NEUROSURGERY, 93(4), 618-625, OCT 2000
  117. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 19(3), 507-512, 20010401
  118. Distinct pattern of p53 phosphorylation in human tumors, Oncogene, 20(26), 3341-3347, 20010401
  119. Involvement of telomere shortening and telomerase in cell aging and immortalization (M. Goto Ed.),, 147-163, 20010401
  120. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas., Pathobiology, 69, 219-224, 20010401
  121. Distinct pattern of p53 phosphorylation in human tumors, ONCOGENE, 20(26), 3341-3347, JUN 7 2001
  122. Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas, INTERNATIONAL JOURNAL OF ONCOLOGY, 19(3), 507-512, SEP 2001
  123. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas, PATHOBIOLOGY, 69(4), 219-224, 2001
  124. Expression and distribution of human telomerqase catalytic component, hTERT, in human breast tissues., Anticancer Research, 22, 4101-4108, 20020401
  125. Association of p16(INK4a) and pRb inactivation with immortalization of human cells, CARCINOGENESIS, 23(12), 2111-2117, DEC 2002
  126. Expression and distribution of human telomerase catalytic component, hTERT, in human breast tissues, ANTICANCER RESEARCH, 22(6C), 4101-4107, NOV-DEC 2002
  127. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformd by Epstein-Barr virus., DNA and Cell Biology, 20030401
  128. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus, DNA AND CELL BIOLOGY, 22(11), 727-735, NOV 2003
  129. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus., Cancer Research, 64, 3361-3364, 20040401
  130. WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus. Cancer Genet., Cytogenet., 152, 95-100, 20040401
  131. Establishment of lifespan-extended human astrocytes with normal phenotypes by introduction of telomerase gene., Tissue Cult. Res. Commun., 23, 59-69, 20040401
  132. Telomeres and telomerase in hepatocellular carcinoma., Recent Res. Devel. Cancer, 6, 191-210, 20040401
  133. Terminal telomere repeats are actually short in telomerase-negative immortal human cells., Biol. Pharm. Bull., 27, 1932-1938, 20040401
  134. Terminal telomere repeats are actually short in telomerase-negative immortal human cells., Biological & Pharmaceutical Bulletin, 27, 1932-1938, 20041201
  135. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus, CANCER RESEARCH, 64(10), 3361-3364, MAY 15 2004
  136. WRN gene and other genetic factors affecting immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus, CANCER GENETICS AND CYTOGENETICS, 152(2), 95-100, JUL 15 2004
  137. Terminal telomere repeats are actually short in telomerase-negative immortal human cells, BIOLOGICAL & PHARMACEUTICAL BULLETIN, 27(12), 1932-1938, DEC 2004
  138. G1P3, An interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial mediated apoptosis in gastric cancer cell line TMK-1., Cancer Immunol. Immunoth., 54(8), 729-740, 20050401
  139. Establishment of cementoblast cell lines from rat cementum lining cells by transfection with temperature-sensitive simian virus-40 T-antigen gene., BONE, 37, 220-226, 20050401
  140. Establishment of immortalized clonal cells derived from periodontal ligament cells by induction of the hTERT gene., Journal of Oral Science, 47(4), 177-184, 20051201
  141. G-tail telomere HPA: simple measurement of human single-stranded telomeric overhangs, Nature Methods, 2(11), 829-831, 20051101
  142. IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3., Biochem. Biophys. Res. Commun., 337(1), 201-208, 20051111
  143. G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell, CANCER IMMUNOLOGY IMMUNOTHERAPY, 54(8), 729-740, AUG 2005
  144. IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 337(1), 201-208, NOV 11 2005
  145. G-taff teLomere HPA: simple measurement of human single-stranded telomeric overhangs, NATURE METHODS, 2(11), 829-831, NOV 2005
  146. Overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil on gastric cancer cell lines, ONCOLOGY, 70(6), 458-464, 2006
  147. Microgravity potentiates stem cell proliferation while sustaining the capability of differentiation., Stem Cells Dev, 15(6), 921-929, 20061201
  148. Characterization of established cementoblast-like cell lines from human cementum lining cells in vitro and in vivo., Bone, 39(5), 1035-1042, 20061101
  149. G-Quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3' telomeric overhang in cancer cells., Oncogene, 25(13), 1955-1966, 20060323
  150. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres., Cell, 126(1), 49-62, 20060714
  151. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination., European Molecular Biology Organization, 25(21), 5180-5190, 20061101
  152. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence., Nature Cell Biology, 8(11), 1291-1297, 20061101
  153. Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome., American Journal of Medical Genetics, 140(4), 358-367, 20060215
  154. Monoallelic BUB1B mutations and defective mitotic-spindle checkpoint in seven families with premature chromatid separation (PCS) syndrome, AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 140A(4), 358-367, FEB 15 2006
  155. G-quadruplex stabilization by telomestatin induces TRF2 protein dissociation from telomeres and anaphase bridge formation accompanied by loss of the 3 ' telomeric overhang in cancer cells, ONCOGENE, 25(13), 1955-1966, MAR 23 2006
  156. Telomere and telomerase in age related diseases, SEIKAGAKU, 78(3), 230-241, MAR 2006
  157. Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres, CELL, 126(1), 49-62, JUL 14 2006
  158. Mitogenic signalling and the p16(INK4a)-Rb pathway cooperate to enforce irreversible cellular senescence, NATURE CELL BIOLOGY, 8(11), 1291-U63, NOV 2006
  159. Characterization of established cementoblast-like cell lines from human cementum-lining cells in vitro and in vivo, BONE, 39(5), 1035-1042, NOV 2006
  160. POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination, EMBO JOURNAL, 25(21), 5180-5190, NOV 1 2006
  161. Immortalization and characterization of human dental pulp cells with odontoblastic differentiation., Archives of Oral Biology, 52(8), 727-731, 20070801
  162. Telomerase activation induces elongation of the telomeric single-stranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells., Biochemical and biophysical research communications, 926-932, 20070223
  163. Quantitative proteomic analysis of human breast epithelial cells with differential telomere length, BBRC, 356(4), 942-947, 20070318
  164. Telomerase activation induces elongation of the telomeric single-stranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells., BBRC, 353(4), 926-932, 20070223
  165. Immortalization and characterization of pleomorphic adenoma cells by transfection with the hTERT gene., International Journal Of Oncology, 31(2), 339-344, 20070801
  166. Telomerase activation induces elongation of the telomeric single-stranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 353(4), 926-932, FEB 23 2007
  167. Quantitative proteomic analysis of human breast epithelial cells with differential telomere length, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 356(4), 942-947, MAY 18 2007
  168. Telomere elongation by a mutant tankyrase 1 without TRF1 poly(ADP-ribosyl)ation, EXPERIMENTAL CELL RESEARCH, 314(5), 1115-1124, MAR 10 2008
  169. Role of menin in the regulation of telomerase activity in normal and cancer cells, INTERNATIONAL JOURNAL OF ONCOLOGY, 33(2), 333-340, AUG 2008
  170. Establishment of functional telomerase immortalized human hepatocytes and a hepatic stellate cell line for telomere-targeting anticancer drug development, CANCER SCIENCE, 101(7), 1678-1685, JUL 2010
  171. A Chiral Wedge Molecule Inhibits Telomerase Activity, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 132(11), 3778-3782, MAR 24 2010
  172. Cooperation of DNA-PKcs and WRN helicase in the maintenance of telomeric D-loops, AGING-US, 2(5), 274-284, MAY 2010
  173. Pin1 Associates with and Induces Translocation of CRTC2 to the Cytosol, Thereby Suppressing cAMP-responsive Element Transcriptional Activity, JOURNAL OF BIOLOGICAL CHEMISTRY, 285(43), 33018-33027, OCT 22 2010
  174. Increased telomerase activity and hTERT expression in human salivary gland carcinomas, ONCOLOGY LETTERS, 2(5), 845-850, SEP-OCT 2011
  175. Two unrelated patients with MRE1 1A mutations and Nijmegen breakage syndrome-like severe microcephaly, DNA REPAIR, 10(3), 314-321, MAR 7 2011
  176. miR-22 represses cancer progression by inducing cellular senescence, JOURNAL OF CELL BIOLOGY, 193(2), 409-424, APR 18 2011
  177. Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly., DNA Repair (Amst), 20110301
  178. Telomere G-Overhang Length Measurement Method 2: G-Tail Telomere HPA, Methods in Molecular Biology, 735, 55-61, 20110301
  179. Mutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repair, NATURE GENETICS, 44(5), 593-+, MAY 2012
  180. Human telomerase reverse transcriptase and glucose-regulated protein 78 increase the life span of articular chondrocytes and their repair potential, BMC MUSCULOSKELETAL DISORDERS, 13, APR 2 2012
  181. Matrix Metalloproteinase-13 (MMP-13) Directly and Indirectly Promotes Tumor Angiogenesis, JOURNAL OF BIOLOGICAL CHEMISTRY, 287(46), 38716-38728, NOV 9 2012
  182. The role of exosomes and microRNAs in senescence and aging, ADVANCED DRUG DELIVERY REVIEWS, 65(3), 368-375, MAR 2013
  183. Two Distinct Modes of ATR Activation Orchestrated by Rad17 and Nbs1, CELL REPORTS, 3(5), 1651-1662, MAY 2013
  184. Introduction of a Single Transporter Gene ABCA3 Directs RLE–6TN to More Type II–like Alveolar Epithelial Cells, MEMBRANE, 38(5), 246-253, 20130801
  185. MicroRNAs in Cancer: The 22nd Hiroshima Cancer Seminar/The 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43(5), 579-582, MAY 2013
  186. Generation of Human Induced Pluripotent Stem (Ips) Cells in Serum- and Feeder-Free Defined Culture and TGF-B1 Regulation of Pluripotency, PLOS ONE, 9(1), JAN 29 2014
  187. CBP-93872 Inhibits NBS1-Mediated ATR Activation, Abrogating Maintenance of the DNA Double-Strand Break-Specific G(2) Checkpoint, CANCER RESEARCH, 74(14), 3880-3889, JUL 15 2014
  188. TERT attenuated ER stress-induced cell death, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 447(2), 378-382, MAY 2 2014
  189. Infection with Porphyromonas gingivalis Exacerbates Endothelial Injury in Obese Mice, PLOS ONE, 9(10), OCT 21 2014
  190. Mutations in the Gene Encoding the E2 Conjugating Enzyme UBE2T Cause Fanconi Anemia, AMERICAN JOURNAL OF HUMAN GENETICS, 96(6), 1001-1007, JUN 4 2015
  191. Inhibition of telomerase causes vulnerability to endoplasmic reticulum stress-induced neuronal cell death, NEUROSCIENCE LETTERS, 629, 241-244, 20160826
  192. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paper, JOURNAL OF EXTRACELLULAR VESICLES, 6, 2017
  193. Werner Syndrome-specific induced pluripotent stem cells: recovery of telomere function by reprogramming, FRONTIERS IN GENETICS, 6, 20150129
  194. Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles, STEM CELLS TRANSLATIONAL MEDICINE, 6(8), 201708
  195. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations, STEM CELLS, 36(3), 434-445, 201803
  196. Levels of tight junction protein CLDND1 are regulated by microRNA-124 in the cerebellum of stroke-prone spontaneously hypertensive rats, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 498(4), 817-823, 20180415
  197. TERT enhances the survival rate of human fibroblasts under endoplasmic reticulum, Golgi apparatus, and lysosomal stresses, BIOTECHNOLOGY LETTERS, 40(6), 915-922, 201806
  198. Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017, JOURNAL OF EXTRACELLULAR VESICLES, 7(1), 20180517
  199. Chromosome 4q25 Variant rs6817105 Bring Sinus Node Dysfunction and Left Atrial Enlargement, SCIENTIFIC REPORTS, 8, OCT 1 2018
  200. Cell-based chemical fingerprinting identifies telomeres and lamin A as modifiers of DNA damage response in cancer cells, SCIENTIFIC REPORTS, 8, OCT 4 2018

Invited Lecture, Oral Presentation, Poster Presentation

  1. Senescence-associated EVs act as tumor suppressors in the tumor microenvironment, Hidetoshi Tahara, International Soclety for Extracellular Vesicies 2015, 2015/04/25, Without Invitation
  2. Liquid Biopsy by using telomere and microRNA, JASIS2015, 2015/09/04, With Invitation
  3. "Non-coding RNAs Senescence-associated EVs from fibroblasts act as tumor suppressor at the tumor microenvironment.", Hidetoshi Tahara, 2016/02/18, Without Invitation
  4. DNA Damage Response in Human Induced Pluripotent Stem Cells, Akira Shimamoto,Harunobu Kagawa,Hidehiko Kawai,Tetsushi Sakuma,Takashi Yamamoto,Bunsyo Shiotani,Hidetoshi Tahara, ICRR2015, 2015/05/25, Without Invitation
  5. Stable propagation of human pluripotent stem cells by dual inhibition of PKC and ERK signaling, 2015/05/26, Without Invitation
  6. A large-scale membrane proteome analysis in scirrhous gastric cancer cell, 2015/05/26, Without Invitation
  7. High-content screening of senescence-inducible microRNAs, 2015/05/26, Without Invitation
  8. Analysis of senescence-associated miRNA that suppress pancreatic cancer, 2015/05/26, Without Invitation
  9. Generation of Werner syndrome-specific iPS cells and challenges towards clinical application, 2015/05/26, Without Invitation
  10. Role of phage display technology to proteomics, 2015/07/23, Without Invitation
  11. miR-486 has potential as nucleic acid medicine, 2015/08/27, Without Invitation
  12. Senescence associated microRNA suppress cell proliferation in pancreatic cancer, 2015/08/27, Without Invitation
  13. Understanding the mechanisms of the PRPF19 siRNA-mediated anti-tumor effect, 2015/08/27, Without Invitation
  14. Cell-derived extracellular vesicle regulates cellular senescence, 2015/08/27, Without Invitation
  15. The analysis of biological significance of extracellular vesicles in replicative senescence, 2015/08/27, Without Invitation
  16. FunctionalanalysisofmiR-486inpancreaticcancer, 2015/10/10, Without Invitation
  17. Identification of novel senescence-associated microRNAs in human fibroblasts, 2015/10/08, Without Invitation
  18. DepletionofPRPF19regulatescellfatebetweencellular senescence and cell death, 2015/10/10, Without Invitation
  19. Thenovelmoleculartargetsforanti-cancerdrugtargeting transcription factors, 2015/10/10, Without Invitation
  20. Depletion of PRPF19 regulates cell fate between cellular senescence and cell death, 2015/12/03, Without Invitation
  21. Histone variant H3.3 depletion induces cellular senescence in human diploid fibroblasts, 2015/12/02, Without Invitation
  22. Extracellular RNA is promising biomarker for eary detection of cancers, Hidetoshi Tahara, Yukie Nishiyama,Yumiko Koui,Yuki Yamamoto,Genki Nishimura,Masaki Kinehara,Akira Shimamoto,Morito Okada,Hidetoshi Tahara, ISEV2017, 2017/05/19, Without Invitation, Toronto,Canada
  23. MicroRNA and exosome in Aging, Hidetoshi Tahara, 2017/06/15, With Invitation
  24. "An in vitro model for cancer stem cell dormancy and recurrence using tetinducible reprogramming system", 2017/07/01, With Invitation
  25. Screening of senescence-inducible microRNAs for cancer therapy, 2017/07/01, Without Invitation
  26. miRNA in aging and cancer, 2017/08/28, With Invitation
  27. Next-Generation Sequence analysis of exosomal small RNA isolated from cell culture media., 2017/08/30, Without Invitation
  28. Identification of serum preparation method that can get consistent circulating ncRNA profile., 2017/08/31, Without Invitation
  29. Senescence-associated microRNAs act as tumor suppressor hor both cancer stem cells and anti-cancer drug cancer cells, Hidetoshi Tahara, 2nd Global Insight Conference on Breast Cancer, 2017/09/05, Without Invitation, Rome
  30. "Cancer dormancy induced by Dox-inducible cancer stem cell model is maintained by BMP signaling", 2017/09/30, Without Invitation
  31. "Novel senescence-associated microRNAs inhibit proliferation of intractable cancer cells", 2017/09/30, Without Invitation
  32. The effect of TRF2 inhibitors in cancer cells, 2017/09/30, Without Invitation
  33. PRPF19 is a novel potent molecular target for tumor suppression, 2017/09/30, Without Invitation
  34. Validation of circulating microRNA using NGS, 2017/11/01, With Invitation
  35. Inhibition of cancer cell growth by senescence-inducible miRNA, 2016/05/25, Without Invitation
  36. Apoptotic Effect of Senescence-inducible microRNAs on Human Cancer Cell Lines, Masaki Kinehara,Yuki Yamamoto,Saori Fukunaga,Akira Shimamoto,Hidetoshi Tahara, 2016/06/24, Without Invitation
  37. The Significant Function Of EVs In Aging And Cancer, Hidetoshi Tahara, Extracellular Vesicles 2016, 2016/07/12, Without Invitation, Cambridge, UK
  38. Nucleic Acid Therapeutics targeting microRNAs, 2016/07/30, With Invitation
  39. p16-dependent induction of cell death by senescence-inducible microRNA in pancreatic cancer cells., 2016/08/31, Without Invitation
  40. The potential for applying PRPF19 siRNA to anti-cancer therapeutics, 2016/09/01, Without Invitation
  41. The potential for applying PRPF19 siRNA to anti-cancer therapeutics, 2016/09/14, Without Invitation
  42. Application of senescence-inducible microRNAs for cancer therapy, 2016/10/06, With Invitation
  43. Induction of cancer stem cell dormancy and recurrence by Dox-inducible secondary reprogramming system, 2016/10/06, Without Invitation
  44. Screening of senescence-associated microRNAs having anti- proliferative effect in human cancer cells, 2016/10/08, Without Invitation
  45. Biogenesisandbiologicalactivitiesofexosomesderivedfrom replicative senescent fibroblast cells, 2016/10/08, Without Invitation
  46. Circulating microRNAs as novel promising biomarkers for early detection of Tongue Cancer, Hidetoshi Tahara, ESMO ASIA, 2017/01/16, Without Invitation, シンガポール
  47. The association between glycation of sueface proteins on extracellular vesicles in serum and aging, 2017/12/06, Without Invitation
  48. Senescence-associated microRNAs suppress malignant pleural mesothelioma cells, 2017/12/06, Without Invitation
  49. Nucleic acid medicine based senescence-associated microRNAs for cancer therapy, 2017/12/06, Without Invitation
  50. Mechanism of p53 activation via silenceing of PRPF19 in cellular senescence, 2017/12/06, Without Invitation
  51. Small non - coding RNA as biomarker promising early detection of pancreatic cancer, 2017/12/07, Without Invitation
  52. Development of inhibitor of telomere binding protein using DSE-FRET assay, 2017/12/07, Without Invitation
  53. Discovery and function analysis of RelA-DNA binding inhibitor using NF-kB DSE-FRET assay, 2017/12/07, Without Invitation
  54. Senescence cell - derived extracellular vesicles repress tumor growth, 2017/12/08, Without Invitation
  55. Senescence cell - derived extracellular vesicles repress tumor growth, 2017/12/09, Without Invitation
  56. Application of exRNA and Circulating RNA for Early Detection of Cancer, Hidetoshi Tahara, Extracellular Vesicles as Biomarkers of Disease, 2017/12/13, Without Invitation
  57. Extracelluar vesicles derived from senescencet cells repress tumour growth via miRNAs, Mariko Ikuo,Megumi Okada, Shigeyuki Teranishi,Masaki Kinehara,Akira Shimamoto,Hidetoshi Tahara, ISEV2018, 2018/05/05, Without Invitation, Barcelona(Reino de España)
  58. Extracelluler small non-coding RNAs as promising biomarkers for early cancer detection, Yukie Nishiyama,Yumiko Koi,Genki Nishimura,Eri Kojima,Morihito Okada,Hidetoshi Tahara, ISEV2018, 2018/05/05, Without Invitation, Barcelona(Reino de España)
  59. Development of novel TRF2 inhibitor, Yoshitomo Shiroma,Go Fujita, Hidetoshi Tahara, EMBO Workshop, 2018/05/02, Without Invitation, Troia(Portugal)
  60. A novel mechanism of p53-dependent cellular senescence by silencing of PRPF19, 2018/08/31, Without Invitation
  61. A novel mechanism of p53-dependent cellular senescence by silencing of PRPF19, 2018/08/30, Without Invitation
  62. Novel Senescence-Associated microRNA suppress malignant pleural mesothelioma, 2018/08/31, Without Invitation
  63. Novel Senescence-Associated microRNA suppress malignant pleural mesothelioma, 2018/08/29, Without Invitation
  64. The relationship between human aging and advanced glycation end products of extracellular vesicles in serum., 2018/08/29, Without Invitation
  65. Age-related expression change of circulating small non-coding RNAs, 2018/08/29, Without Invitation
  66. Exploration of hemolysis-associated small non-coding RNA by Next Generation Sequence, 2018/08/30, Without Invitation
  67. MicroRNAs,isomiRs and tRFs are promising biomarkers as liquid biopsy for breast cancer detection., 2018/09/27, Without Invitation
  68. Telomere and microRNA in aging, 2018/10/10, With Invitation
  69. Characterization of extracellular vesicles (EVs) derived exRNA in cancer using NGS, Hidetoshi Tahara, qPCR dPCR & NGS 2019, 2019/03/18, With Invitation, Weihenstephan,Germany

Social Activities

Organizing Academic Conferences, etc.

  1. 2012/08
  2. The 7th JARI Annual Meeting, 2015/08, 2015/08
  3. The 8th JARI Annual Meeting, 2016/08, 2016/08
  4. The 9th JARI Annual Meeting, 2017/08, 2017/09
  5. 2018/08, 2018/08